New diabetes clinical trial: Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients

Published on: October 19, 2023 at 11:00PM
Conditions: Diabetes Mellitus, Type 2
Interventions: Device: Revita® DMR Treatment; Other: Sham procedure
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Fractyl Health, Inc.
Not yet recruiting
https://ift.tt/BLnrqgw